Related Experiment Video
Updated: May 23, 2026

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
Analyzing microarray data of Alzheimer's using cluster analysis to identify the biomarker genes
Satya Vani Guttula1, Apparao Allam, R Sridhar Gumpeny
1Department of Biotechnology, Al-Ameer College of Engineering & IT, Andhra Pradesh, Visakhapatnam 531173, India.
This study identified 24 genes with high expression levels in Alzheimer's disease research. Three genes (SORL1, APP, APOE) are implicated in Alzheimer's, while 21 others may also be associated with the neurodegenerative condition.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Alzheimer's disease is pathologically defined by senile plaques and neurofibrillary tangles in the brain's cortex.
- Understanding gene expression patterns is crucial for elucidating the complex local environment in Alzheimer's.
Purpose of the Study:
- To identify genes with altered expression patterns in Alzheimer's disease.
- To explore potential novel genetic associations with Alzheimer's disease.
Main Methods:
- Utilized Gene Expression Omnibus data for experimental analysis.
- Applied hierarchical cluster analysis and TreeView for gene expression pattern grouping and visualization.
- Identified genes exhibiting high expression levels.
Main Results:
- A list of 24 genes with high expression levels was generated.
- Three key genes (SORL1, APP, APOE) are strongly suspected in causing Alzheimer's disease.
- An additional 21 genes (e.g., TMEM59, CCT4, IGF2R) were identified, potentially associated with Alzheimer's or other diseases.
Conclusions:
- Gene expression dynamics reveal a complex local milieu in Alzheimer's disease.
- The identified genes, particularly SORL1, APP, and APOE, warrant further investigation for their role in Alzheimer's pathogenesis.
- The study highlights potential novel genetic targets for Alzheimer's disease research.
More Related Videos
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
DNA Microarrays
Alzheimer Disease l: Introduction